Optimizing the management of intermediate-stage hepatocellular carcinoma: Current trends and prospects

por Torimura, Takuji, Iwamoto, Hideki
Publicado 2021

Second fertility preservation surgery for early relapse of seromucinous borderline ovarian tumors

por Kanno, Motoko, Iwamoto, Hideki, Umezawa, Satoshi
Publicado 2021

Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity

por Iwamoto, Hideki, Shimose, Shigeo, Shirono, Tomotake, Niizeki, Takashi, Kawaguchi, Takumi
Publicado 2023

Clinical significance of the discrepancy between radiological findings and biochemical responses in atezolizumab plus bevacizumab for hepatocellular carcinoma

por Iwamoto, Hideki, Shimose, Shigeo, Niizeki, Takashi, Koga, Hironori, Torimura, Takuji
Publicado 2022

Clinical practice guidelines and real-life practice in hepatocellular carcinoma: A Japanese perspective

por Koga, Hironori, Iwamoto, Hideki, Suzuki, Hiroyuki, Shimose, Shigeo, Nakano, Masahito, Kawaguchi, Takumi
Publicado 2023

Effects of canagliflozin on growth and metabolic reprograming in hepatocellular carcinoma cells: Multi-omics analysis of metabolomics and absolute quantification proteomics (iMPAQT...

por Nakano, Dan, Kawaguchi, Takumi, Iwamoto, Hideki, Hayakawa, Masako, Koga, Hironori, Torimura, Takuji
Publicado 2020

Serotonin in the orbitofrontal cortex enhances cognitive flexibility

por Hyun, Jung Ho, Hannan, Patrick, Iwamoto, Hideki, Blakely, Randy D., Kwon, Hyung-Bae
Publicado 2023

Indication of suitable transarterial chemoembolization and multikinase inhibitors for intermediate stage hepatocellular carcinoma

por Shimose, Shigeo, Kawaguchi, Takumi, Iwamoto, Hideki, Niizeki, Takashi, Shirono, Tomotake, Tanaka, Masatoshi, Koga, Hironori, Torimura, Takuji
Publicado 2020

PlGF-induced VEGFR1-dependent vascular remodeling determines opposing antitumor effects and drug resistance to Dll4-Notch inhibitors

por Iwamoto, Hideki, Zhang, Yin, Seki, Takahiro, Yang, Yunlong, Nakamura, Masaki, Wang, Jian, Yang, Xiaojuan, Torimura, Takuji, Cao, Yihai
Publicado 2015

Safety of Early Bevacizumab Administration after Central Venous Port Placement for Patients with Colorectal Cancer

por Shigyo, Hirona, Suzuki, Hiroyuki, Tanaka, Toshimitsu, Moriyama, Etsuko, Shimotsuura, Yasutaka, Nagasu, Sachiko, Iwamoto, Hideki, Akagi, Yoshito, Murotani, Kenta, Kawaguchi, Takumi, Miwa, Keisuke
Publicado 2023

Primary Treatment with Molecular‐Targeted Agents for Hepatocellular Carcinoma: A Propensity Score‐matching Analysis

por Nakano, Masahito, Kuromatsu, Ryoko, Niizeki, Takashi, Okamura, Shusuke, Iwamoto, Hideki, Shimose, Shigeo, Shirono, Tomotake, Noda, Yu, Kamachi, Naoki, Koga, Hironori, Torimura, Takuji
Publicado 2020

Association between contrast enhancement on contrast-enhanced CT and lenvatinib effectiveness in hepatocellular carcinoma

por Okamura, Shusuke, Shimose, Shigeo, Niizeki, Takashi, Kamachi, Naoki, Noda, Yu, Shirono, Tomotake, Iwamoto, Hideki, Nakano, Masahito, Kuromatsu, Ryoko, Koga, Hironori, Torimura, Takuji
Publicado 2022

Evaluating the therapeutic effect of lenvatinib against advanced hepatocellular carcinoma by measuring blood flow changes using contrast‐enhanced ultrasound

por Kamachi, Naoki, Nakano, Masahito, Okamura, Shusuke, Niizeki, Takashi, Iwamoto, Hideki, Shimose, Shigeo, Shirono, Tomotake, Noda, Yu, Kuromatsu, Ryoko, Koga, Hironori, Torimura, Takuji
Publicado 2021

Ablation of endothelial VEGFR1 improves metabolic dysfunction by inducing adipose tissue browning

por Seki, Takahiro, Hosaka, Kayoko, Fischer, Carina, Lim, Sharon, Andersson, Patrik, Abe, Mitsuhiko, Iwamoto, Hideki, Gao, Yanyan, Wang, Xinsheng, Fong, Guo-Hua, Cao, Yihai
Publicado 2018

Interrogating the Spatiotemporal Landscape of Neuromodulatory GPCR Signaling by Real-Time Imaging of cAMP in Intact Neurons and Circuits

por Muntean, Brian S., Zucca, Stefano, MacMullen, Courtney M., Dao, Maria T., Johnston, Caitlin, Iwamoto, Hideki, Blakely, Randy D., Davis, Ronald L., Martemyanov, Kirill A.
Publicado 2018

Correction: Ablation of endothelial VEGFR1 improves metabolic dysfunction by inducing adipose tissue browning

por Seki, Takahiro, Hosaka, Kayoko, Fischer, Carina, Lim, Sharon, Andersson, Patrik, Abe, Mitsuhiko, Iwamoto, Hideki, Gao, Yanyan, Wang, Xinsheng, Fong, Guo-Hua, Cao, Yihai
Publicado 2020

Antiangiogenic and Antitumor Activities of Aflibercept, a Soluble VEGF Receptor-1 and -2, in a Mouse Model of Hepatocellular Carcinoma

por Torimura, Takuji, Iwamoto, Hideki, Nakamura, Toru, Abe, Mitsuhiko, Ikezono, Yu, Wada, Fumitaka, Sakaue, Takahiko, Masuda, Hiroshi, Hashimoto, Osamu, Koga, Hironori, Ueno, Takato, Yano, Hirohisa
Publicado 2016

Case Report: Exacerbation of varices following atezolizumab plus bevacizumab treatment of hepatocellular carcinoma: A case series and literature review

por Suzuki, Hiroyuki, Iwamoto, Hideki, Shimose, Shigeo, Niizeki, Takashi, Shirono, Tomotake, Noda, Yu, Kamachi, Naoki, Yamaguchi, Taizo, Nakano, Masahito, Kuromatsu, Ryoko, Koga, Hironori, Kawaguchi, Takumi
Publicado 2022

Efficacy of Lenvatinib Combined with Transcatheter Intra-Arterial Therapies for Patients with Advanced-Stage of Hepatocellular Carcinoma: A Propensity Score Matching

por Shimose, Shigeo, Iwamoto, Hideki, Niizeki, Takashi, Tanaka, Masatoshi, Shirono, Tomotake, Moriyama, Etsuko, Noda, Yu, Nakano, Masahito, Suga, Hideya, Kuromatsu, Ryoko, Torimura, Takuji, Koga, Hironori, Kawaguchi, Takumi
Publicado 2023

High expression of the putative cancer stem cell marker, DCLK1, in rectal neuroendocrine tumors

por IKEZONO, YU, KOGA, HIRONORI, ABE, MITSUHIKO, AKIBA, JUN, KAWAHARA, AKIHIKO, YOSHIDA, TAKAFUMI, NAKAMURA, TORU, IWAMOTO, HIDEKI, YANO, HIROHISA, KAGE, MASAYOSHI, SATA, MICHIO, TSURUTA, OSAMU, TORIMURA, TAKUJI
Publicado 2015